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Autoimmune Pancreatitis Presenting with Mass 
and Biliary Obstruction 
Amber A. Frank, Michael D. Morse, Benjamin R. Smith, and Kitt Shaffer, M.D., Ph.D.
We report a case of autoimmune pancreatitis in a 31-year-old man with signs and symptoms of 
biliary tract obstruction. Evaluation with sonography, computed tomography, and ultimately en-
doscopic retrograde cholangiopancreatography, demonstrated a 5 by 2 cm hypoechoic, hypodense 
mass near the head of the pancreas that extended into the porta hepatis. Common bile duct 
obstruction with proximal dilatation was present. Following fine needle aspiration of the mass, 
cytology showed findings consistent with autoimmune pancreatitis. Treatment with common bile 
duct stent was followed by resolution of the patient’s symptoms.
The term autoimmune pancreatitis is used to 
describe a heterogeneous set of pancreatic conditions 
which are associated with characteristic laboratory and 
histologic findings [1]. The prevalence of autoimmune 
pancreatitis has been estimated to constitute ap-
proximately 5-10% of patients diagnosed with chronic 
pancreatitis [2]. The mean age at diagnosis of 55 years, 
and while autoimmune pancreatitis occurs in both sexes, 
Introduction it is twice as common in men as in women [3]. Imaging 
of patients with autoimmune pancreatitis commonly 
reveals an enlarged homogenously disorganized pancreas 
and regional lymphadenopathy. When confirmed with 
serum IgG4 levels or response to treatment, the diagno-
sis of autoimmune pancreatitis can be made.
A 31-year-old man originally from Brazil presented 
to the Emergency Department with a chief complaint of 
one week of moderate epigastric pain accompanied by 
nausea and vomiting. The pain was of moderate severity 
and was burning in nature, with radiation to the right 
and left upper quadrants but not his back. He also noted 
that his vomiting occurred after every meal, and his wife 
confirmed that he had lost weight (exact amount was 
unknown) in the previous week in association with his 
inadequate nutritional intake. Upon further question-
ing, he also reported a one-week history of jaundice and 
dark brown urine as well as a four-day history of acholic 
diarrhea. He noted that he had never experienced symp-
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Figure 1A-B. 31-year-old man with autoimmune pancreatitis. Sonography shows (A) common bile duct dilatation without 
intrahepatic biliary ductal dilatation, and (B) hypoechoic mass in the region of the pancreatic head.
toms like this on any previous occasions. He denied 
any history of known hepatitis, intravenous drug use, 
tattoos, infectious exposure, or any recent use of medica-
tions or illicit drugs. The patient was further questioned 
about risk factors for acute pancreatitis, pancreatic 
cancer, and lymphoma. He denied any significant his-
tory of alcohol use, stating that he limited his consump-
tion to approximately one beer per month, and he also 
denied any history of colicky abdominal pain or known 
gallstones. He had no smoking history or family history 
of gastrointestinal cancer or any other gastrointestinal 
disease. He denied any night sweats, fevers, lymph-
adenopathy, fatigue, or weight loss over the preceding 
months. He had previously been in excellent health and 
had an unremarkable past medical history.
On physical exam in the Emergency Department, 
the patient was a thin, jaundiced man who appeared 
his stated age. Vital signs were all within normal ranges. 
Cardiac and pulmonary exams were both normal, 
and the patient had no palpable lymphadenopathy 
of the neck or supraclavicular region. The abdominal 
exam revealed tenderness to palpation throughout the 
upper abdomen and right lower quadrant; however, 
the remainder of the examination was unremarkable, 
with normal bowel sounds, no palpable masses or 
organomegaly, no fluid wave, no Murphy’s sign, and 
no evidence of prior trauma or incisions. Labs drawn 
in the Emergency Department showed elevated levels 
of alkaline phospatase, total and direct bilirubin, AST 
and ALT; urinalysis also showed dark urine containing 
elevated levels of bilirubin. Lipase and amylase were not 
significantly elevated. CBC and differential were normal 
except for a hematocrit of 41.4.
Based on the physical exam and initial laboratory 
data, the patient was presumed to have a conjugated 
hyperbilirubinemia caused by obstruction of the com-
mon bile duct; he was therefore sent for ultrasound 
imaging (Fig. 1). Abdominal ultrasound showed a 5 x 
2 cm hypoechoic mass in the region of the pancreatic 
head as well as a 1 x 2 cm hypoechoic area in the porta 
hepatis. A 9 mm dilatation of the common bile duct was 
also visualized, but there was no evidence of intrahe-
patic biliary ductal dilatation. No pericholecystic fluid, 
gallbladder wall thickening, or cholelithiasis was appar-
ent. Based on this imaging, the patient was suspected to 
have a pancreatic neoplasm constricting the common 
bile duct, with possible lymphadenopathy of the porta 
hepatis. 
A pancreatic CT with oral and intravenous contrast 
was performed on the following day to evaluate this pos-
sibility. The CT showed a 5 x 3 cm enhancing, heteroge-
neous mass located in the region of the pancreatic head, 
with extension into the porta hepatis (Fig. 2). Slight 
intrahepatic duct dilatation and distension of the gall-
bladder were also noted, and the possibilities of enlarged 
lymph nodes and lymphoma were raised.
The patient was scheduled for ERCP (Fig. 3) and 
stenting of the common bile duct two days following 
his presentation to the Emergency Department. ERCP 
showed a normal pancreatic duct, non-beaded narrow-
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Autoimmune pancreatitis is a rare disorder of un-
known etiology that can easily masquerade as a pancre-
atic or biliary neoplasm. Clinically, patients with auto-
immune pancreatitis do not usually present with severe 
abdominal pain or acute pancreatitis, but jaundice is 
common (63% in one large series) [2]. Imaging in cases 
of autoimmune pancreatitis is often non-specific, but 
nevertheless serves as one of the cornerstones of diagno-
Discussion
Figure 2A-B. CT of the abdomen shows (A) enhancing, heterogeneous pancreatic head mass, and (B) slight intrahepatic 
duct dilatation and gallbladder distension
ing of the distal common bile duct, and dilatation of the 
common bile duct proximal to the area of stricture. A 
stent was placed across the site of narrowing.
Ultrasound-guided fine needle aspiration of the 
pacreatic head mass was performed to assess further the 
nature of the lesion. Cytology showed benign glandu-
lar cells, neutrophils, lymphocytes, plasma cells, and 
fibrosis, consistent with either chronic pancreatitis or 
autoimmune pancreatitis. Based on the constellation of 
imaging findings, cytology, and clinical history, a diag-
nosis of autoimmune pancreatitis was proposed. Despite 
experiencing a brief post-ERCP pancreatitis, the pa-
tient’s symptoms largely resolved in the week following 
the stenting; the patient’s hyperbilirubinemia had also 
decreased. Additional laboratory tests including CEA, 
Ca-19-9, IgG4, ANA, strongyloides and schistosomiasis 
serologies were all negative.
sis of the disorder. Classic CT findings include a focal 
mass in the head of the pancreas [4] or sausage-shaped 
enlargement of the pancreas with homogeneous attenu-
ation, moderate enhancement, and a peripheral rim of 
hypoattenuating ‘halo’ [1]. Normal lobular architecture 
of the gland is often lost, but fat stranding is generally 
limited, and some enlargement of regional lymph nodes 
is typical. Distinguishing autoimmune pancreatitis 
from pancreatic carcinoma on CT is often not possible, 
and patients can present on CT with extra-pancreatic 
findings, including focal lesions in the lung, kidneys, 
and peri-aortic soft tissue. Neither MRI nor ultrasound 
has been found to provide more definitive diagnostic 
assistance [1].
An increase in serum IgG4 levels is common in 
autoimmune pancreatitis, and autoantibodies against 
lactoferrin and carbonic anhydrase II have also been 
reported. Additionally, autoimmune pancreatitis is fre-
quently associated with other autoimmune conditions, 
including rheumatoid arthritis, Sjogren’s syndrome, and 
inflammatory conditions [1, 5]. Still, the etiology of 
autoimmune pancreatitis is not well understood. On pa-
thology, autoimmune pancreatitis has a typical histolog-
ic appearance, with a “periductal collar” that consists of 
an infiltrate of lymphocytes and plasma cells [6]. Some 
experts believe that the gold standard for diagnosis of 
autoimmune pancreatitis is pathology that shows such 
an infiltration and periductal fibrosis. However, such 
pathology can also be seen in chronic pancreatitis related 
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Figure 3A-B. ERCP shows (A) normal pancreatic duct, non-beaded narrowing of the distal common bile duct, and (B) proxi-
mal dilatation of the common bile duct.
to alcohol use [1]. Such pathologic specimens can be 
acquired by laparotomy, though fine needle aspiration 
and core biopsy have also been used.
There is a lack of consensus on the diagnosis of 
autoimmune pancreatitis, but a recent review suggested 
an algorithm for establishing the diagnosis. If diffuse 
gland enlargement is seen, laboratory tests should be 
performed to search for evidence of an autoimmune 
process, to include IgG4, IgG, antilactoferrin antibody, 
anti-carbonic anhydrase II antibody, anti-smooth-
muscle antibody, and antinuclear antibody. If there is 
laboratory evidence of autoimmune disease-or if there is 
a lack of laboratory evidence but a presence of sugges-
tive pathology (either through biopsy or fine needle 
aspirate)-then a trial of corticosteroid treatment is 
indicated. If this therapy produces a characteristically 
quick and sustained response, then the diagnosis of au-
toimmune pancreatitis is confirmed. If there is a paucity 
of laboratory or pathologic evidence, then surgical resec-
tion of the area of focal mass is warranted, and if the 
pathology of the surgical resection does show findings 
consistent with autoimmune pancreatitis, then a trial of 
corticosteroid therapy is reasonable [1]. In each of the 
above steps, a quick and sustained response to corticos-
teroid therapy is considered diagnostic for autoimmune 
pancreatitis [7,8]. Corticosteroids also produce a resolu-
tion of any associated focal lesions, including associated 
lung and kidney lesions [1].
Our case likely represents a presentation of auto-
immune pancreatitis due to the characteristic imag-
ing (large, diffusely disorganized mass in the area of 
the pancreas and regional lymphadenopathy) and the 
results of the fine needle aspirate (lymphocytic infiltrate 
and plasma cell infiltrate). As discussed, pancreatic 
cancer and lymphoma were originally considered in 
the differential but were ruled out based on cytology. 
Primary sclerosing cholangitis was considered, but this 
diagnosis is less likely because in this disorder there is 
often a beaded narrowing of the distal common bile 
duct, whereas our patient presented with non-beaded 
narrowing. Alcoholic pancreatitis was also considered, 
but patient and his family report no history of alcohol 
use. This case demonstrates typical clinical features of 
autoimmune pancreatitis including moderate pain, 
jaundice, normal pancreatic enzymes, and imaging that 
was initially suggestive of pancreatic cancer. 
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